Skip to content

Review of SVF Gel Injection in Nasolabial Facial Rejuvenation

investigating the effect of svf + non cross-linked hyaluronic acid in rejuvenating the nasolabial region of patients referred to the skin clinic and comparing it with SVF injection alone for nasolabial rejuvenation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200127046282N60
Enrollment
10
Registered
2025-12-01
Start date
2025-12-21
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging. Atrophic disorder of skin

Interventions

Intervention 1: Control group: Patients undergo an injection with two cc of SVF in one session on one side of the laugh line area (nasolabial fold). Intervention 2: Intervention group: Patients underg

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age from 18 to 65 years The patient has nasolabial lines.

Exclusion criteria

Exclusion criteria: Active infection in the facial area Pregnancy Breastfeeding History of cancer

Design outcomes

Primary

MeasureTime frame
The amount of wrinkles. Timepoint: Before, one and three months after the intervention. Method of measurement: Visio face.

Secondary

MeasureTime frame
Satisfaction rate. Timepoint: After completing the intervention. Method of measurement: Comparison of the amount of wrinkle reduction in patients after treatment compared to before by the patient herself (score 0 - 10).;Inflammation. Timepoint: Half an hour after the end of the intervention. Method of measurement: Visit.;Intensity of pain. Timepoint: At the time of the intervention. Method of measurement: Questionnaire and visit (Scoring 0 to 10).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

dr.sonazare@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026